Market Performance - In December 2025, the three major A-share indices showed a fluctuating trend in the early part of the month and strengthened in the latter part, with the Shanghai Composite Index achieving 11 consecutive days of gains [1] - The Shanghai Composite Index, Shenzhen Component Index, and ChiNext Index rose by 2.06%, 4.17%, and 4.93% respectively in December [1] - Commodity futures such as gold, silver, copper, aluminum, and lithium carbonate also experienced strong upward trends in December [1] Private Equity Fund Performance - In this market context, over 51% of the 352 private equity products under a major private equity firm reached historical net value highs last month [2] - Among the products, stock strategy products were the most numerous, with 249 products (225 quantitative long and 8 subjective long), accounting for over 70% [2] - Quantitative products comprised 307 products (with 180 being index-enhanced), making up nearly 90% of the total, while non-quantitative products accounted for only 45 [3] Notable Private Equity Firms - Twelve major private equity firms had all their products (with at least three products displayed on the private equity ranking website) reach historical net value highs last month [4] - The firms ranked by average returns for 2025 include Lingjun Investment, Ningbo Huafang Quantitative, Chengqi Private Equity, and others, with eight firms being quantitative private equity [4][5] - Notably, Ningbo Huafang Quantitative had 10 products (all index-enhanced) with an average return exceeding ***% for 2025, ranking second among quantitative private equity firms [8][9] Performance Rankings - The top five products by average returns for 2025 came from firms such as Yuanshin Investment, Yinye Investment, Longqi Technology, Lingjun Investment, and Pingfang Investment, with two subjective long products taking the top two spots [14] - The threshold for the top 20 products in terms of returns over the past three years was close to ***%, with notable products from Abama Investment and Honghu Private Equity [19][21] - Over the past five years, the top five products were from Honghu Private Equity, Jiukun Investment, Minghuan Investment, Tianyan Capital, and Century Frontier, with a similar threshold for the top 20 products [23][25]

Core Insights - The private equity market has seen significant fluctuations this year, with a focus on products that can navigate market cycles and provide long-term returns for investors [1] Group 1: Performance of "Double Ten" Billion Private Equity Products - A total of 13 products have made it to the "Double Ten" list, indicating they have been established for at least ten years and achieved an annualized return of over 10% in the last decade [2] - Among these products, 11 are based on subjective long/short strategies, highlighting the enduring value of active stock selection by fund managers [2] - The remaining 2 products utilize macro strategies to generate returns by understanding economic cycles [2] Group 2: Investment Strategies and Insights - Fund managers exhibit clear investment philosophies and strong execution, with a focus on dividend and technology sectors [3] - The founder of Xiva Asset, Liang Hong, emphasizes a portfolio that includes stable cash flow assets like oil and insurance, alongside growth sectors such as consumer electronics and innovative pharmaceuticals [3] - Dongfang Gangwan's Dan Bin suggests that artificial intelligence is not a short-term trend but rather a long-term cycle that could last over a decade, urging investors to focus on not missing out on this era [3]

Core Viewpoint - The macro strategy private equity funds have shown remarkable performance in 2023, with an average return of 24.91% in the first ten months, significantly surpassing previous years' performance [2]. Group 1: Performance Overview - The average return of macro strategy private equity funds from 2021 to 2024 is 13.90%, -9.20%, -4.18%, and 20.63% respectively, indicating a substantial improvement in 2023 [2]. - The top-performing macro strategy products in the 50 billion and above category achieved an average return of 20.15% in the first ten months of 2023 [4]. Group 2: Top Products by Size - In the 50 billion and above category, the top three macro strategy products are managed by Juki Investment, Yinye Investment, and Yuanxin Investment, all of which are large private equity firms [4][7]. - The leading product in the 20-50 billion category is managed by Luyuan Private Equity, with an average return of 27.27% [9][13]. - The top product in the 5-20 billion category is managed by Zhong'an Huifu, achieving a return of 26.55% [14][16]. - In the 0-5 billion category, Yize Investment, Jiali Asset, and Sanhua Asset are the top three, with an average return of 34.80% [17][20]. Group 3: Notable Fund Managers - Zhao Weihua, the investment director at Yuanxin Investment, has a decade of macro research and investment experience, contributing to the strong performance of the "Yuanxin Multi-Asset Strategy" [8]. - Li Bei from Banxia Investment is recognized as a pioneer in the domestic macro hedge fund sector, with the "Banxia Balanced Macro Hedge" product achieving impressive returns [8]. - Luyuan Private Equity's fund manager, Lu Wentao, emphasizes the long-term support for gold prices due to ongoing fiscal and monetary stimulus policies [13].

Core Viewpoint - The article discusses the performance of private equity products in the A-share market over the past three years, highlighting the scarcity of products that have maintained impressive returns and drawdown performance amidst market volatility caused by geopolitical conflicts, the pandemic, and trade wars [2]. Summary by Categories Overall Performance of Private Equity Products - In 2023, the average return for 662 private equity products with over 10 billion in assets was 30.15%, with an average Sharpe ratio of 2.53. Over the past three years, 430 of these products achieved an average return of 79.96% and a Sharpe ratio of 1.12 [3]. Performance by Company Size - 100 billion and above: 662 products, 30.15% return, 2.53 Sharpe; 430 products, 79.96% return, 1.12 Sharpe - 50-100 billion: 372 products, 25.59% return, 2.15 Sharpe; 242 products, 53.73% return, 0.88 Sharpe - 20-50 billion: 630 products, 29.42% return, 2.29 Sharpe; 388 products, 75.14% return, 1.33 Sharpe - 10-20 billion: 573 products, 30.50% return, 2.25 Sharpe; 328 products, 74.08% return, 1.07 Sharpe - 5-10 billion: 745 products, 31.57% return, 1.91 Sharpe; 449 products, 82.89% return, 0.91 Sharpe - 0-5 billion: 2057 products, 28.59% return, 1.82 Sharpe; 1169 products, 72.52% return, 0.84 Sharpe - Total: 5039 products, 29.34% return, 2.06 Sharpe; 3006 products, 74.13% return, 0.98 Sharpe [3]. Top Performing Private Equity Products - The top three subjective long products over the past three years are from Junzhijian Investment, Kaishi Private Equity, and Dongfang Gangwan, with average returns of 99.85% and a Sharpe ratio of approximately 1.04 [4]. - The leading product is "Junzhijian Junyue" managed by Zhang Yong, with significant returns and a high Sharpe ratio [5][6]. - The top three quantitative long products are from Ming Shi Fund, Maoyuan Quantitative, and Abama Investment, with an average return of 85.34% and a Sharpe ratio of approximately 1.02 [7]. - The leading product is "Ming Shi Spring 28" managed by Yang Kun, achieving high returns and a notable Sharpe ratio [8][9]. - The top three market-neutral products are from Ping Fang He Investment, Mengxi Investment, and Ming Huan Investment, with an average return of 85.34% and a Sharpe ratio of approximately 1.02 [10]. - The leading product is "Ping Fang He Cai Ying Ping Heng 1" managed by Lü Jieyong and Fang Zhuangxi, with impressive returns and a high Sharpe ratio [12]. - The top three multi-asset strategy products are from Borun Yintai Investment, Ming Huan Investment, and Honghu Private Equity, with an average return of 64.79% and a Sharpe ratio of approximately 1.09 [13].

Core Viewpoint - In October, A-shares maintained a high-level fluctuation, with the Shanghai Composite Index rising by 1.85%, while the Shenzhen Component Index and the ChiNext Index fell by 1.1% and 1.56% respectively. Despite this, 69% of the private equity products from billion-yuan private equity firms reached historical highs in net value, indicating resilience in certain investment strategies amidst market volatility [2][3][4]. Group 1: Market Performance - The overall trading volume in the A-share market shrank compared to previous months, reflecting a cautious market sentiment [2]. - Among billion-yuan private equity products, 407 products achieved historical net value highs, with quantitative products leading the way [2][3]. Group 2: Product Strategy and Performance - The majority of high-performing products were equity strategies, with 327 products, of which 201 were quantitative long strategies and 103 were subjective long strategies [2][3]. - 24 billion-yuan private equity firms had over 80% of their products reach historical highs, with 13 firms achieving 100% of their products hitting new highs [3][4]. Group 3: Notable Firms and Products - Notable firms such as Dongfang Gangwan and Jukun Investment had over 90% of their products reach historical highs, with Dongfang Gangwan leading with 77 out of 80 products achieving this milestone [4][9]. - The top-performing products over the past year were primarily from firms like Yuanxin Investment and Juku Investment, with significant returns attributed to investments in the AI sector [8][12]. Group 4: Long-term Performance - Over the past three years, macro strategy products from firms like Juku Investment and Honghu Private Equity dominated the top rankings, indicating a strong performance in this investment category [12][16]. - The five-year performance rankings were led by Honghu Private Equity and Jukun Investment, showcasing the effectiveness of their investment strategies over a longer horizon [16][19].

Core Viewpoint - The article discusses the performance of non-debt private equity products in the A-share market, highlighting those that have achieved consecutive positive returns over the years, indicating the fund managers' ability to navigate market fluctuations [2][10]. Summary by Sections 2023 Performance - In 2023, among private equity companies managing over 500 million, there were 1,731 non-debt private equity products, with 1,026 (59.27%) achieving consecutive positive returns [2]. - The threshold for the top 20 products in cumulative returns for 2023 was set at ***% [2]. - The majority of the top 20 products (15) were subjective long strategies, with only one product from a billion-dollar private equity firm, Oriental Harbor [2]. Top Products in 2023 - The top five products based on returns were managed by: - Qian Jun from Chiying Private Equity - Zhou Yifeng from Beiheng Fund - Chen Yongbao from Ding Tai Si Fang (Shenzhen) - Wu Gengxin from Zhun Jin Investment - Shi Hao from Shanghai Ge Ru Private Equity [3]. 2021 Performance - For the period from 2021, there were 855 non-debt private equity products, with 184 (21.52%) achieving consecutive positive returns [10]. - The threshold for the top 20 products in cumulative returns for 2021 was also set at ***% [10]. - Half of the top 20 products were subjective long strategies, with a notable presence of quantitative long products [10]. Top Products in 2021 - The top five products were managed by: - He Wenling from Qianhai Guoen Capital - Liu Zhiyong from Caoben Investment - Li Ting from Gongqingcheng Guangju Xinghe Private Equity - Ma Changhai from Hengbang Zhaofeng - Li Jiabin from Qianhai Haifu Asset [11]. 2019 Performance - In 2019, there were 377 non-debt private equity products, with 54 (14.32%) achieving consecutive positive returns [15]. - The threshold for the top 20 products in cumulative returns for 2019 was set at ***% [15]. - The top 20 products included seven subjective long products, with a mix of quantitative long, macro strategies, and composite strategies [15]. Top Products in 2019 - The top five products were managed by: - Yang Zhongxian from Jilu Asset - Chen Yu from Shennong Investment - Yao Qicong from Jiukun Investment - Liang Wentao from Honghu Private Equity - Yu Zilong from Shanghai Yuanlai Private Equity [16][22].

Core Insights - The A-share market continued its strong performance in September, with all three major indices rising, while gold prices surged due to multiple factors including the onset of the Federal Reserve's rate cut cycle and central bank gold purchases [2] - Despite the strong market performance, the subjective long/short and quantitative long strategies underperformed in September, with average returns of 3.11% and 1.37% respectively, while macro strategies excelled with an average return of 4.08% [2] - Over a longer time frame, macro strategies have shown superior performance, with average returns of 22.45% and 75.33% over the year and the past three years respectively, highlighting their flexibility in capturing asset rotation opportunities [2] Strategy Performance Summary - **Macro Strategy**: 218 products, average return of 4.08% this year, 22.45% over the year, and 75.33% over three years [3] - **Subjective Long/Short**: 2120 products, average return of 3.11% this year, 34.08% over the year [3] - **Quantitative Long**: 862 products, average return of 1.37% this year, 36.94% over the year [3] - **Other Derivative Strategies**: 16 products, average return of 5.17% this year, 18.77% over the year [3] Top Macro Strategy Products - For products with over 5 billion in assets, the top three macro strategies over the past three years are managed by 久期投资 and 泓湖私募, with average returns of 69.86% [4][5] - The leading product in the 10-50 billion category is "路远睿泽稳增" managed by 路文韬, with significant returns [9] - In the 0-10 billion category, "石泉宏观对冲" managed by 孙旭 leads with impressive returns [12] Notable Fund Managers - 梁文涛 from 泓湖私募 is recognized for his strong performance and has a background in macro strategies [4] - 李蓓 from 半夏投资 has shown a significant rebound in performance this year after previous underperformance [6] - 路文韬 from 路远私募 has focused on gold and military sectors, indicating a strategic shift in asset allocation [9]

Core Viewpoint - Macro strategy, based on macroeconomic analysis for asset allocation, has shown better investment performance during economic cycles, gaining increasing attention in recent years [2] Group 1: Macro Strategy Performance - In mature overseas markets, macro strategy is recognized as a core strategy for hedge funds, particularly excelling during market volatility, as exemplified by Bridgewater's Pure Alpha II, which rose approximately 11.3% in 2025 while the S&P 500 fell over 5% [2] - In the domestic market, macro strategy is still in its early stages but has been developing rapidly, with 131 macro strategy products showing performance in the last six months [2] - Although the average return for macro strategies was negative in May, the long-term performance is impressive, with an average return of 45.67% over the past three years, ranking fourth among all secondary strategies [2][3] Group 2: Performance Rankings - The top 20 macro strategy products in the last six months had a minimum return threshold of ***%, with an average return of ***% [4] - Notable products include "Luyuan Ruize Stable Growth" from Luyuan Private Equity, "Yize Global Macro No. 2" from Yize Investment, and "Duration Macro Multi-Strategy" from Duration Investment, which ranked in the top three [4][8] - Three products from billion-dollar private equity firms made the list, including "Honghu Stable Macro Hedge A" from Honghu Private Equity and "Lerui Stock-Bond Rotation No. 1" from Lerui Asset [4] Group 3: Yearly and Three-Year Performance - The top 20 macro strategy products over the past year had a minimum return threshold of ***%, with the top three being "Shenzhen Shanzhe Private Equity," "Duration Investment," and "Luyuan Private Equity" [9][13] - Over the past three years, the top 20 macro strategy products had a minimum return threshold of ***%, with "Luyuan Ruize Stable Growth" again leading the list [15][19] - The consistent performance of "Luyuan Ruize Stable Growth" across both six-month and three-year periods highlights its strong investment strategy [15]

Core Viewpoint - The article provides an overview of the private equity market in China, highlighting the number of private equity firms, their performance, and the distribution of firms across major cities as of May 2025. Group 1: Overview of Private Equity Firms - As of May 2025, there are 7,789 private equity firms in China, with 5,616 located in first-tier cities (Beijing, Shanghai, Guangzhou, Shenzhen, Hangzhou), accounting for 72.10% of the total [2]. - The number of top-tier private equity firms (with assets over 5 billion) is highest in Shanghai (86 firms), followed by Beijing (47 firms) and Shenzhen (18 firms) [2]. Group 2: Performance Metrics by Region - In Beijing, 582 products have an average annual return of 21.30% and a May return of 1.74% [4]. - Shanghai's 1,145 products show an average annual return of 19.68% and a May return of 1.68% [13]. - Guangzhou's 228 products have an impressive average annual return of 28.40% and a May return of 3.28% [19]. - Shenzhen's 705 products yield an average annual return of 23.55% and a May return of 3.81% [24]. - Hangzhou's 268 products report an average annual return of 26.06% and a May return of 2.01% [31]. Group 3: Notable Private Equity Firms - In Beijing, the top private equity firms include "止于至善投资" with a notable annual return and several other firms with significant assets [6][9]. - In Shanghai, "海南致衍私募" leads with a strong performance, followed by "系综(上海)私募" and "上海紫杰私募" [12][16]. - In Guangzhou, "海南香元私募" ranks first with a high annual return, followed by "广州千泉私募" and "广州守正用奇" [19][21]. - In Shenzhen, "富延资本" is the top firm with a strong performance, followed by "能敬投资控股" and "君子乾乾" [27][29]. - In Hangzhou, "云起量化" leads the performance metrics, followed by "浩坤昇发资产" and "橡木资产" [35]. Group 4: Other Regions - Outside first-tier cities, there are 2,173 private equity firms, with 25 firms having assets over 5 billion [36][39]. - The average annual return for 972 products in other regions is 23.24%, with the top three firms being "一久私募基金," "尚阳资管," and "优波资本" [39].

Core Insights - The average return of private equity fund managers in the past year reached 21.84%, significantly outperforming the market [2] - Stock fund managers showed the highest average return of 25.52%, benefiting from the recovery of the A-share market since "924" [2][4] - Fund managers with assets under management between 0-5 billion yuan had the best performance, with average returns of 23.38% [2][4] By Strategy - Stock Strategy: 1471 managers, 2853 products, total AUM of 2330.34 billion yuan, average return of 25.52% [4] - Futures and Derivatives: 393 managers, 652 products, total AUM of 393.50 billion yuan, average return of 17.27% [4] - Multi-Asset: 297 managers, 531 products, total AUM of 476.29 billion yuan, average return of 19.32% [4] - Bond: 179 managers, 409 products, total AUM of 445.17 billion yuan, average return of 9.70% [4] - Combination Funds: 63 managers, 94 products, total AUM of 42.59 billion yuan, average return of 24.17% [4] By Company Size - Managers with over 10 billion yuan AUM: 114 managers, 586 products, total AUM of 998.51 billion yuan, average return of 20.66% [4] - Managers with 5-10 billion yuan AUM: 400 managers, 707 products, total AUM of 468.51 billion yuan, average return of 23.38% [4] - Managers with 0-5 billion yuan AUM: 1442 managers, 2104 products, total AUM of 750.51 billion yuan, average return of 22.52% [4] Top Performers - Wang Chen from Jiukun Investment topped the list among managers with over 10 billion yuan AUM [5][9] - Wu Xing from Shenzhen Kaifeng Investment led the 50-100 billion yuan category [10][11] - Chen Yu from Shennong Investment ranked first among 20-50 billion yuan managers, focusing on innovative drugs [15][19] - Sun Jie from Nengjing Investment led the 10-20 billion yuan category [22][23] - Hu Shiyuan from Wantao Private Equity topped the 5-10 billion yuan category [29][30] - Tan Guanhua from Hainan Xiangyuan Private Equity led the 0-5 billion yuan category [30][32]